Multiple predicted immune and cell-cycle related proteins

The term Multiple predicted immune and cell-cycle related proteins refers to a broad functional category of proteins rather than a single, specific therapeutic target. This designation is commonly used in high-throughput proteomic and transcriptomic studies to describe a cluster of molecules that are co-regulated or associated with specific biological states, such as the immune response or cell cycle progression. For instance, research into Combined Metabolic Activators (CMAs) has identified various proteins within this group that respond to metabolic interventions in diseases like Alzheimer's and COVID-19 (Adil et al., 2021, medRxiv). Because this category encompasses a diverse array of enzymes, receptors, and signaling molecules, it lacks a unified mechanism of action or a specific pharmacological profile. It is generally considered an incorrect or overly broad entry for a drug target database, as it does not represent a discrete entity that can be selectively modulated by a single drug. Consequently, any therapeutic approach involving this group would involve complex, multi-target interactions rather than a specific molecular intervention.

Other names

Immune and cell cycle-related protein clusterImmune and cell cycle-related protein group

Not applicable as this is a collective category of proteins rather than a single therapeutic target.